Decitabine

CHEBI:CHEBI_748077

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
DECITABINE
brand_name
DECITABINE
brand_name_base
DECITABINE
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_start_date
20100303
labeler_name
Cipla USA Inc.
product_ndc
75834-190
application_number
ANDA212117
listing_expiration_date
20241231
route
INTRAVENOUS
spl_id
e20c2038-e61d-4c04-8b35-f2ff37a1b8d5
package_ndc
75834-190-01
package_description
1 VIAL in 1 CARTON (75834-190-01) / 20 mL in 1 VIAL
rxcui
636631
package_marketing_start_date
21-MAY-18
manufacturer_name
Cipla USA Inc.
unii
776B62CQ27
spl_set_id
150537a8-10ac-422d-bf33-68b1a408e566
active_ingredient_strength
50 mg/26mL
pharm_class_moa
Nucleic Acid Synthesis Inhibitors [MoA]
pharm_class
Nucleoside Metabolic Inhibitor [EPC]
pharm_class_epc
Nucleoside Metabolic Inhibitor [EPC]
nui
N0000175595
active_ingredient_name
DECITABINE
upc
0375834190013
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class